Market Overview
According to DIResearch's in-depth investigation and research, the global Personalized Cancer Medicine market size will reach 234,438 Million USD in 2025 and is projected to reach 529,052 Million USD by 2032, with a CAGR of 12.33% (2025-2032). Notably, the China Personalized Cancer Medicine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Personalized cancer medicine, also known as precision oncology or personalized oncology, refers to an approach to cancer treatment that takes into account the unique genetic and molecular characteristics of an individual's cancer to tailor therapies specifically to that patient. This approach recognizes that cancer is not a single disease but rather a complex group of diseases with diverse underlying genetic mutations and molecular alterations. By analyzing the genetic profile of a patient's tumor through techniques such as genomic sequencing, molecular profiling, and biomarker analysis, oncologists can identify specific genetic mutations or biomarkers driving the cancer's growth and progression. Based on this information, personalized treatment plans can be developed to target the underlying molecular abnormalities with precision-targeted therapies such as targeted therapies, immunotherapies, or combination therapies. Personalized cancer medicine aims to maximize treatment efficacy while minimizing side effects by selecting therapies that are most likely to be effective for each individual patient based on their unique tumor biology. This approach has revolutionized cancer care by allowing for more precise and effective treatments, leading to improved outcomes and quality of life for many cancer patients.
The major global suppliers of Personalized Cancer Medicine include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Personalized Cancer Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Personalized Cancer Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Personalized Cancer Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Personalized Cancer Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Personalized Cancer Medicine Include:
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
GSK
Exelixis
Regeneron
Innovent
Hengrui Medicine
Personalized Cancer Medicine Product Segment Include:
Cancer Immunotherapy
Targeted Therapy
Personalized Cancer Medicine Product Application Include:
Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Personalized Cancer Medicine Industry PESTEL Analysis
Chapter 3: Global Personalized Cancer Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Personalized Cancer Medicine Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Personalized Cancer Medicine Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Personalized Cancer Medicine Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Personalized Cancer Medicine Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
- 1 Personalized Cancer Medicine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Personalized Cancer Medicine Product by Type
- 1.2.1 Cancer Immunotherapy
- 1.2.2 Targeted Therapy
- 1.3 Personalized Cancer Medicine Product by Application
- 1.3.1 Lung Cancer
- 1.3.2 Breast Cancer
- 1.3.3 Prostate Cancer
- 1.3.4 Blood-related Cancer
- 1.3.5 Others
- 1.4 Global Personalized Cancer Medicine Market Size Analysis (2020-2032)
- 1.5 Personalized Cancer Medicine Market Development Status and Trends
- 1.5.1 Personalized Cancer Medicine Industry Development Status Analysis
- 1.5.2 Personalized Cancer Medicine Industry Development Trends Analysis
- 2 Personalized Cancer Medicine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Personalized Cancer Medicine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Personalized Cancer Medicine Market Analysis by Country
- 4.1 Global Personalized Cancer Medicine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Personalized Cancer Medicine Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Personalized Cancer Medicine Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.5 China Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.6 France Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.14 India Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Personalized Cancer Medicine Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Personalized Cancer Medicine Market Revenue by Key Suppliers (2021-2025)
- 5.2 Personalized Cancer Medicine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Personalized Cancer Medicine Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Personalized Cancer Medicine Market Analysis by Type
- 6.1 Global Personalized Cancer Medicine Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Personalized Cancer Medicine Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 AbbVie
- 7.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 AbbVie Personalized Cancer Medicine Product Portfolio
- 7.1.3 AbbVie Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Johnson & Johnson Personalized Cancer Medicine Product Portfolio
- 7.2.3 Johnson & Johnson Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Novartis
- 7.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Novartis Personalized Cancer Medicine Product Portfolio
- 7.3.3 Novartis Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Gilead Sciences
- 7.4.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Gilead Sciences Personalized Cancer Medicine Product Portfolio
- 7.4.3 Gilead Sciences Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Roche
- 7.5.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Roche Personalized Cancer Medicine Product Portfolio
- 7.5.3 Roche Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Bristol-Myers Squibb
- 7.6.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Bristol-Myers Squibb Personalized Cancer Medicine Product Portfolio
- 7.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Amgen
- 7.7.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Amgen Personalized Cancer Medicine Product Portfolio
- 7.7.3 Amgen Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 AstraZeneca
- 7.8.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 AstraZeneca Personalized Cancer Medicine Product Portfolio
- 7.8.3 AstraZeneca Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Merck & Co
- 7.9.1 Merck & Co Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Merck & Co Personalized Cancer Medicine Product Portfolio
- 7.9.3 Merck & Co Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Takeda
- 7.10.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Takeda Personalized Cancer Medicine Product Portfolio
- 7.10.3 Takeda Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Merck KGaA
- 7.11.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Merck KGaA Personalized Cancer Medicine Product Portfolio
- 7.11.3 Merck KGaA Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Seagen
- 7.12.1 Seagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Seagen Personalized Cancer Medicine Product Portfolio
- 7.12.3 Seagen Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Eli Lilly
- 7.13.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Eli Lilly Personalized Cancer Medicine Product Portfolio
- 7.13.3 Eli Lilly Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Ono Pharmaceutical
- 7.14.1 Ono Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Ono Pharmaceutical Personalized Cancer Medicine Product Portfolio
- 7.14.3 Ono Pharmaceutical Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Pfizer
- 7.15.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Pfizer Personalized Cancer Medicine Product Portfolio
- 7.15.3 Pfizer Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 GSK
- 7.16.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 GSK Personalized Cancer Medicine Product Portfolio
- 7.16.3 GSK Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 Exelixis
- 7.17.1 Exelixis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 Exelixis Personalized Cancer Medicine Product Portfolio
- 7.17.3 Exelixis Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.18 Regeneron
- 7.18.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.18.2 Regeneron Personalized Cancer Medicine Product Portfolio
- 7.18.3 Regeneron Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.19 Innovent
- 7.19.1 Innovent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.19.2 Innovent Personalized Cancer Medicine Product Portfolio
- 7.19.3 Innovent Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.20 Hengrui Medicine
- 7.20.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.20.2 Hengrui Medicine Personalized Cancer Medicine Product Portfolio
- 7.20.3 Hengrui Medicine Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Personalized Cancer Medicine Industry Chain Analysis
- 8.2 Personalized Cancer Medicine Product Downstream Application Analysis
- 8.2.1 Global Personalized Cancer Medicine Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Personalized Cancer Medicine Revenue and Forecast by Application (2020-2032)
- 8.3 Personalized Cancer Medicine Typical Downstream Customers
- 8.4 Personalized Cancer Medicine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook